文献速递肿瘤 PET/CT放射性药物与辐射防护

[18F]FAPI-42与[18F]FDG PET/CT在系统性血管炎评估中的比较

Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-11-27

该回顾性研究纳入2020年9月至2022年3月间接受双示踪剂PET/CT的30例系统性血管炎患者,比较[18F]FAPI与[18F]FDG的病灶检出率和半定量参数。结果显示[18F]FAPI PET/CT检出更多病灶(161/168 vs 145/168,P=0.005),且在60%(18/30)患者中显示更广泛的血管受累,TBR肝脏和TBR血液均高于FDG。作者认为[18F]FAPI PET/CT是系统性血管炎诊断和治疗监测的有前景的影像方法。

要点

  • [18F]FAPI PET/CT检出病灶数161/168 vs [18F]FDG 145/168(P=0.005),并在60%(18/30)患者中显示更广泛血管受累。
  • [18F]FAPI的TBR肝脏(中位数9.59 vs 3.15,P<0.001)和TBR血液(中位数5.45 vs 4.20,P=0.006)高于[18F]FDG;SUVmax无显著差异(中位数5.94 vs 5.46,P=0.517)。
  • FAPI PET/CT阳性病灶总数与ESR(rs=0.478,P=0.008)和CRP(rs=0.486,P=0.006)呈中度相关;6例治疗后随访显示SUVmax、TBR和病灶数下降,与临床缓解平行。

核心结论

  • [18F]FAPI PET/CT显像是系统性血管炎诊断和治疗监测的有前景的影像方法。

研究设计与样本

  • 回顾性分析2020年9月至2022年3月接受[18F]FDG和[18F]FAPI双示踪剂PET/CT显像的系统性血管炎患者。
  • 共纳入30例患者(13例男性,17例女性;平均年龄52.5±17.2岁),包括17例大血管血管炎、10例抗中性粒细胞胞质抗体相关性血管炎、2例白塞病和1例结节性多动脉炎。
  • 阳性病灶定义为血管/血管外病灶示踪剂摄取高于周围本底,且不能归因于示踪剂的生理性生物分布。
  • 比较[18F]FAPI与[18F]FDG的血管/血管外病灶检出率和半定量值(SUVmax、TBR血液和TBR肝脏),并分析示踪剂摄取范围和程度与炎症标志物水平的相关性。

主要发现

  • [18F]FDG PET/CT在93.3%(28/30)患者中有阳性发现,[18F]FAPI PET/CT在所有患者(100%)中有阳性发现(P=0.500)。
  • 与[18F]FDG PET/CT相比,[18F]FAPI PET/CT检出更多病灶(161/168 vs 145/168,P=0.005),并在60%(18/30)患者中显示更广泛的血管受累。
  • SUVmax在[18F]FAPI与[18F]FDG间无显著差异(中位数5.94 vs 5.46,P=0.517);[18F]FAPI的TBR肝脏较高(中位数9.59 vs 3.15,P<0.001),TBR血液较高(中位数5.45 vs 4.20,P=0.006)。
  • FAPI PET/CT阳性病灶总数与红细胞沉降率(rs=0.478,P=0.008)和C反应蛋白(rs=0.486,P=0.006)呈中度相关。
  • 6例患者治疗后随访FAPI PET/CT显示SUVmax、TBR和检出病灶数下降,与临床缓解平行。

关键数值与推荐

  • 阳性病灶定义为血管/血管外病灶示踪剂摄取高于周围本底,且不能归因于示踪剂的生理性生物分布。
  • [18F]FDG PET/CT阳性患者比例93.3%(28/30)vs [18F]FAPI PET/CT 100%(30/30),P=0.500。
  • 病灶检出数[18F]FAPI 161/168 vs [18F]FDG 145/168,P=0.005。
  • SUVmax中位数[18F]FAPI 5.94 vs [18F]FDG 5.46,P=0.517;TBR肝脏中位数[18F]FAPI 9.59 vs [18F]FDG 3.15,P<0.001;TBR血液中位数[18F]FAPI 5.45 vs [18F]FDG 4.20,P=0.006。
  • FAPI PET/CT阳性病灶总数与ESR相关性rs=0.478(P=0.008),与CRP相关性rs=0.486(P=0.006)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文为回顾性分析。
  • 治疗后随访FAPI PET/CT仅6例患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The role of fibroblast activation protein (FAP)-targeted imaging in systemic vasculitis is currently unclear. We aimed to evaluate the clinical value of fluorine-18-labeled FAP inhibitor 42 ([18F]FAPI-42) in patients with systemic vasculitis and to compare with [18F]fluorodeoxyglucose (FDG) imaging. METHODS: Patients with systemic vasculitis who underwent dual-tracer PET/CT([18F]FDG and [18F]FAPI) imaging from September 2020 to March 2022 were retrospectively analyzed. Positive lesions are defined as vascular/extravascular lesions with increased tracer uptake above surrounding background, which cannot be attributed to the physiologic biodistribution of the radiotracer. The vascular/extravascular lesion detection rate and semiquantitative values (SUVmax, TBRblood and TBRliver) of [18F]FAPI and [18F]FDG were compared, and the correlation between the extent and range of tracer uptake and levels of inflammatory markers was investigated. RESULTS: Thirty patients (13 males and 17 females; mean age, 52.5 ± 17.2 years) with systemic vasculitis were included (17 large vessel vasculitis, 10 anti-neutrophil cytoplasmic antibody-associated vasculitis, 2 Behcet's disease and 1 polyarteritis nodosa). [18F]FDG PET/CT had positive findings in 93.3% (28/30) of patients, while [18F]FAPI PET/CT had positive findings in all patients (100%, P = 0.500). Compared with [18F]FDG PET/CT, [18F]FAPI PET/CT detected more lesions (161/168 vs. 145/168, P = 0.005), and more extensive vascular involvement in 60% (18/30) of patients. Although SUVmax did not differ significantly between [18F]FAPI and [18F]FDG (median, 5.94 vs. 5.46, P = 0.517), [18F]FAPI had higher TBRliver (median, 9.59 vs. 3.15, P < 0.001) and TBRblood (median, 5.45 vs. 4.20, P = 0.006). The total number of positive lesions in FAPI PET/CT show a moderate correlation with erythrocyte sedimentation rate (rs =0.478, P = 0.008) and C-reactive protein (rs =0.486, P = 0.006). After treatment, follow-up FAPI PET/CT of 6 patients showed decreased SUVmax, TBR and number of detected lesions, paralleling the clinical remission. CONCLUSION: [18F]FAPI PET/CT imaging is a promising imaging modality for the diagnosis and therapeutic monitoring of systemic vasculitis.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Zhong K, Chen H, Hou P, et al. Comparison of [18F]FAPI-42 and [18F]FDG PET/CT in the evaluation of systemic vasculitis. Eur J Nucl Med Mol Imaging. 2024. PMID: 39601894. doi:10.1007/s00259-024-06986-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。